-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QcFy2a+5AZ49oG+722qujHJFKTMImT3P2FDeGJwNBS1phqZIQhI2rHZZg/98tee3 2pAPCi01ScoRuiKg+RXHhg== 0000051396-99-000010.txt : 19990217 0000051396-99-000010.hdr.sgml : 19990217 ACCESSION NUMBER: 0000051396-99-000010 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19980930 FILED AS OF DATE: 19990216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MALLINCKRODT INC /MO CENTRAL INDEX KEY: 0000051396 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 361263901 STATE OF INCORPORATION: NY FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: SEC FILE NUMBER: 001-00483 FILM NUMBER: 99540898 BUSINESS ADDRESS: STREET 1: 675 MCDONNELL BLVD STREET 2: PO BOX 5840 CITY: ST LOUIS STATE: MO ZIP: 63134 BUSINESS PHONE: 3146542000 MAIL ADDRESS: STREET 1: 7733 FORSYTH BLVD CITY: ST LOUIS STATE: MO ZIP: 63105-1820 FORMER COMPANY: FORMER CONFORMED NAME: MALLINCKRODT INC /MO DATE OF NAME CHANGE: 19970625 FORMER COMPANY: FORMER CONFORMED NAME: MALLINCKRODT GROUP INC DATE OF NAME CHANGE: 19940322 FORMER COMPANY: FORMER CONFORMED NAME: IMCERA GROUP INC DATE OF NAME CHANGE: 19920703 10-Q/A 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 -------------------------------- FORM 10-Q/A No. 1 X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF --- THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 1998 OR --- TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 1-483 -------------------------------- MALLINCKRODT INC. (Exact name of registrant as specified in its charter) New York 36-1263901 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 675 McDonnell Boulevard St. Louis, Missouri 63134 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 314-654-2000 -------------------------------- Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X. No . Applicable Only To Issuers Involved In Bankruptcy Proceedings During The Preceding Five Years: Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes . No . Applicable Only To Corporate Issuers: Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. 71,341,966 shares excluding 15,774,323 treasury shares as of October 31, 1998. This Form 10-Q/A No. 1 is hereby filed with respect to that certain Quarterly Report on Form 10-Q for the three months ended September 30, 1998 of Mallinckrodt Inc. filed with the Securities and Exchange Commission on November 10, 1998 (the Form 10-Q). Part I, Items 1 and 2 "Financial Information" and Part II, Item 6 "Exhibits and Reports on Form 8-K" of the Form 10-Q are hereby amended and restated in their entirety due to the change in the amount of the purchase price of Nellcor Puritan Bennett Incorporated that was allocated to purchased research and development and to provide additional disclosures as follows. PART I. FINANCIAL INFORMATION Item 1. Financial Statements (Unaudited). The accompanying interim condensed consolidated financial statements of Mallinckrodt Inc. (the Company or Mallinckrodt) do not include all disclosures normally provided in annual financial statements. These financial statements, which should be read in conjunction with the consolidated financial statements contained in Mallinckrodt's Annual Report on Form 10-K/A No. 1 for the year ended June 30, 1998, are unaudited but include all adjustments which Mallinckrodt's management considers necessary for a fair presentation. These adjustments consist of normal recurring accruals except as discussed in Notes 1, 2 and 3 of the Notes to Condensed Consolidated Financial Statements. Interim results are not necessarily indicative of the results for the fiscal year. All references to years are to fiscal years ended June 30 unless otherwise stated. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In millions, except per share amounts) Three Months Ended September 30, --------------------- 1998 1997 -------- -------- Net sales $ 591.2 $ 454.6 Operating costs and expenses: Cost of goods sold 318.3 275.8 Selling, administrative and general expenses 172.4 119.0 Purchased research and development 306.3 Research and development expenses 33.9 27.7 Other operating income, net (1.5) -------- -------- Total operating costs and expenses 524.6 727.3 -------- -------- Operating earnings (loss) 66.6 (272.7) Interest and other nonoperating income, net .9 9.2 Interest expense (20.6) (18.3) -------- -------- Earnings (loss) from continuing operations before income taxes 46.9 (281.8) Income tax provision 15.2 9.1 -------- -------- Earnings (loss) from continuing operations 31.7 (290.9) Discontinued operations 22.6 -------- -------- Earnings (loss) before cumulative effect of accounting change 54.3 (290.9) Cumulative effect of accounting change (8.4) -------- -------- Net earnings (loss) 54.3 (299.3) Preferred stock dividends (.1) (.1) -------- -------- Available for common shareholders $ 54.2 $(299.4) ======== ======== Basic earnings per common share: Earnings (loss) from continuing operations $ .43 $ (4.02) Discontinued operations .31 Cumulative effect of accounting change (.11) -------- -------- Net earnings (loss) $ .74 $ (4.13) ======== ======== Diluted earnings per common share: Earnings (loss) from continuing operations $ .43 $ (4.02) Discontinued operations .31 Cumulative effect of accounting change (.11) -------- -------- Net earnings (loss) $ .74 $ (4.13) ======== ======== (See Notes to Condensed Consolidated Financial Statements on pages 4 through 7.) CONDENSED CONSOLIDATED BALANCE SHEETS (In millions, except share and per share amounts) September 30, June 30, 1998 1998 ------------- ---------- Assets Current assets: Cash and cash equivalent $ 58.1 $ 55.5 Trade receivables, less allowances of $18.3 at September 30 and $16.7 at June 30 452.1 486.3 Inventories 505.6 470.0 Deferred income taxes 108.9 95.2 Other current assets 69.3 61.5 Net current assets of discontinued operations 4.8 --------- --------- Total current assets 1,194.0 1,173.3 Investments and other noncurrent assets, less allowances of $6.2 at September 30 and $5.8 at June 30 154.7 154.5 Property, plant and equipment, net 903.3 894.9 Goodwill, net 980.3 987.0 Technology, net 351.1 364.3 Other intangible assets, net 284.5 282.1 Net noncurrent assets of discontinued operations 12.4 Deferred income taxes 4.8 4.6 --------- --------- Total assets $3,872.7 $3,873.1 ========= ========= Liabilities and Shareholders' Equity Current liabilities: Short-term debt $ 373.1 $ 311.4 Accounts payable 181.1 215.0 Accrued liabilities 468.9 532.0 Income taxes payable 114.5 122.3 Deferred income taxes 4.0 1.4 --------- --------- Total current liabilities 1,141.6 1,182.1 Long-term debt, less current maturities 944.4 944.5 Deferred income taxes 401.8 396.2 Postretirement benefits 170.8 169.2 Other noncurrent liabilities and deferred credits 183.2 175.2 --------- --------- Total liabilities 2,841.8 2,867.2 --------- --------- Shareholders' equity: 4 Percent cumulative preferred stock 11.0 11.0 Common stock, par value $1, authorized 300,000,000 shares; issued 87,116,289 shares 87.1 87.1 Capital in excess of par value 314.9 315.2 Reinvested earnings 1,082.0 1,039.7 Accumulated other comprehensive expense (53.7) (72.6) Treasury stock, at cost (410.4) (374.5) --------- --------- Total shareholders' equity 1,030.9 1,005.9 --------- --------- Total liabilities and shareholders' equity $3,872.7 $3,873.1 ========= ========= (See Notes to Condensed Consolidated Financial Statements on pages 4 through 7.) CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In millions) Three Months Ended September 30, --------------------- 1998 1997 -------- --------- Cash Flows - Operating Activities Net earnings (loss) $ 54.3 $ (299.3) Adjustments to reconcile net earnings (loss) to net cash provided (used) by operating activities: Depreciation 28.8 25.5 Amortization 20.9 12.6 Postretirement benefits 1.7 3.3 (Gains)/losses on asset disposals (37.4) .1 Deferred income taxes (7.4) (8.7) Write-off of purchased research and development 308.3 Sale of inventory stepped up to fair value at acquisition 18.8 Write-off of pre-operating costs 12.5 -------- ---------- 60.9 73.1 Changes in operating assets and liabilities: Trade receivables 41.5 33.8 Inventories (33.5) (17.4) Other current assets (.8) 43.0 Accounts payable, accrued liabilities and income taxes payable, net (112.1) (152.9) Other noncurrent liabilities and deferred credits 6.0 18.4 Other, net 6.7 2.0 -------- ---------- Net cash provided (used) by operating activities (31.3) .0 -------- ---------- Cash Flows - Investing Activities Capital expenditures (27.3) (30.3) Acquisition spending (1,734.6) -------- ---------- Proceeds from asset disposals 55.1 1.3 Net cash provided (used) by investing activities 27.8 (1,763.6) -------- ---------- Cash Flows - Financing Activities Increase in short-term debt 60.5 1,091.8 Proceeds from long-term debt .2 .4 Payments on long-term debt (.4) Issuance of Mallinckrodt common stock .3 10.0 Acquisition of treasury stock (42.5) (9.7) Dividends paid (12.0) (12.1) -------- ---------- Net cash provided by financing activities 6.1 1,080.4 -------- ---------- Increase (decrease) in cash and cash equivalents 2.6 (683.2) Cash and cash equivalents at beginning of period 55.5 808.3 -------- ---------- Cash and cash equivalents at end of period $ 58.1 $ 125.1 ======== ========== (See Notes to Condensed Consolidated Financial Statements on pages 4 through 7.) NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 1. On August 28, 1997, the Company acquired Nellcor Puritan Bennett Incorporated (Nellcor) through an agreement to purchase for cash all the outstanding shares of common stock of Nellcor. The aggregate purchase price of the Nellcor acquisition was approximately $1.9 billion. The acquisition was accounted for under the purchase method of accounting and, accordingly, the results of operations of Nellcor have been included in the Company's consolidated financial statements since September 1, 1997. The purchase price of the acquisition was allocated to the assets acquired and liabilities assumed based upon generally accepted accounting principles and estimated fair values at the date of acquisition. In connection with the Company's filing of a shelf registration for debt securities in December 1997, Mallinckrodt was engaged in discussions with the staff of the Securities and Exchange Commission (SEC) regarding the purchase price allocation related to the acquisition of Nellcor. On January 26, 1999, the Company concluded these discussions with the SEC and, as a result, has agreed to recalculate and restate the amount of purchase price allocated to purchased research and development under a methodology preferred by the SEC as articulated publicly in an SEC letter to the American Institute of Certified Public Accountants (AICPA) in September 1998. The amount of purchased research and development charged to operations in the first quarter of 1998 of $398.3 million has been reduced by $90 million to $308.3 million. Of this amount, $306.3 million related to ongoing operations and $2.0 million related to operations classified as discontinued operations. This one-time noncash acquisition-related cost had no tax benefit. A corresponding $90 million increase in goodwill is being amortized on a straight-line basis over the previously established 30-year amortization period beginning in September 1997. The effects of this change on previously reported Condensed Consolidated Statements of Operations and Condensed Consolidated Balance Sheets are as follows:
Three Months Ended September 30, ----------------------------------------- (In millions, except per 1998 1997 share amounts ----------------------------------------- As As Reported Restated Reported Restated -------- -------- -------- -------- Condensed Consolidated Statements of Operations Selling, administrative and general expenses $ 171.7 $ 172.4 $ 118.8 $ 119.0 Purchased research and development 396.3 306.3 Total operating costs and expenses 523.9 524.6 817.1 727.3 Operating earnings (loss) 67.3 66.6 (362.5) (272.7) Earnings (loss) from continuing operations before income taxes 47.6 46.9 (371.6) (281.8) Earnings (loss) from continuing operations 32.4 31.7 (380.7) (290.9) Earnings (loss) before cumulative effect of accounting change 55.0 54.3 (380.7) (290.9) Net earnings (loss) 55.0 54.3 (389.1) (299.3) Available for common shareholders $ 54.9 $ 54.2 $ (389.2) $ (299.4) Basic earnings per common share: Earnings (loss) from continuing operations $ .44 $ .43 $ (5.26) $ (4.02) Net earnings (loss) $ .75 $ .74 $ (5.37) $ (4.13) Diluted earnings per common share: Earnings (loss) from continuing operations $ .44 $ .43 $ (5.26) $ (4.02) Net earnings (loss) $ .75 $ .74 $ (5.37) (4.13) September 30, 1998 June 30, 1998 ------------------- ------------------- As As Reported Restated Reported Restated -------- -------- -------- -------- Condensed Consolidated Balance Sheets Goodwill, net $ 893.5 $ 980.3 $ 899.5 $ 987.0 Total assets 3,785.9 3,872.7 3,785.6 3,873.1 Reinvested earnings 995.2 1,082.0 952.2 1,039.7 Total shareholders' equity 944.1 1,030.9 918.4 1,005.9 Total liabilities and shareholders' equity 3,785.9 3,872.7 3,785.6 3,873.1 (/TABLE> The sale of Nellcor inventories, which were stepped up to fair value in connection with the allocation of purchase price, resulted in charges of $18.8 million, $11.7 million net of taxes for the quarter ended September 30, 1997. Of this pretax amount, $18.6 million related to ongoing operations and $.2 million related to operations classified as discontinued operations. During 1998, in connection with management's plan to integrate Mallinckrodt and Nellcor into one company, the Company recorded additional purchase liabilities of $50.1 million, $30.8 million net of related tax benefit, which were included in the acquisition cost allocation and related goodwill. The principal actions of the plan included Nellcor employee severance of $37.2 million, Nellcor employee relocation costs of $3.8 million and the elimination of contractual obligations of Nellcor, which had no future economic benefit, of $9.1 million. Approximately $32.1 million of cash expenditures have been incurred through September 30, 1998 and liabilities of $18.0 million related to the Nellcor integration plan remained in accrued liabilities at September 30, 1998. The majority of the remaining cash expenditures will occur in 1999 and, although none are expected, reductions in the estimated liability for these integration activities will be offset against the related goodwill. During 1998, the Company recorded a pretax charge of $19.1 million associated with exiting certain activities related to Mallinckrodt operations that were identified in the Nellcor integration plan. The charge included $17.1 million related to Mallinckrodt employee severance costs and facility exit costs of $2.0 million. Approximately $6.0 million of cash expenditures have been incurred through September 30, 1998. The majority of the remaining cash expenditures will occur in 1999 and no material adjustments to the original reserve are anticipated. 2. The Company sold certain chemical additive product lines in the second quarter of 1998. In the fourth quarter of 1998, the Company sold its catalyst business and Aero Systems division. In June 1998, the Company committed to the sale of the remaining chemical additives business of the catalysts and chemical additives division, and closing of the sale occurred on July 31, 1998. The transaction resulted in a $37.0 million gain on sale, $22.6 million net of taxes, which was included in discontinued operations for the quarter ended September 30, 1998. Earnings from operations were zero for the one month of operations. Included in prior year first quarter discontinued operations are the earnings from operations of the catalysts and chemical additives and Aero Systems divisions, which included $2.2 million of after-tax earnings from operations and a $2.2 million after- tax acquisition accounting charge. 3. The Company elected to early adopt the provisions of the American Institute of Certified Public Accountants SOP 98-5, "Reporting on the Costs of Start-Up Activities" (SOP 98-5), in its financial statements for the year ended June 30, 1998. The effect of adoption of SOP 98-5 was to record a charge of $8.4 million, net of taxes, for the cumulative effect of an accounting change to expense costs that had previously been capitalized prior to July 1, 1997. 4. On October 6, 1994, Augustine Medical, Inc. (Augustine) commenced a patent infringement litigation against Mallinckrodt Inc. and its wholly owned subsidiary, Mallinckrodt Medical, Inc. (collectively, the Company) in the U.S. District Court for the District of Minnesota. Specifically, Augustine alleged that the Company's sale of all five models of its convective warming blankets infringes certain claims of one or more of Augustine's patents. The Company filed counterclaims against Augustine in connection with the above actions alleging unfair competition, antitrust violations, and invalidity of the asserted patents, among other things. The liability phase of the case was tried to a jury in August 1997 and the verdict was that the Company's blankets infringe certain Augustine patents under the doctrine of equivalents, but do not literally infringe the patents. There was also a finding of no willful infringement. On September 22, 1997, the jury awarded damages in the amount of $16.8 million for the period ended September 30, 1997 and the judge put in place an injunction which stopped the Company from manufacturing and selling blankets in the United States. The Company appealed the jury verdicts of liability and damages to the Court of Appeals for the Federal Circuit (a special court for patent appeals that does not involve a jury). The Court of Appeals has stayed the injunction pending the outcome of the Company's appeal, and the Company continues to sell and manufacture blankets in the United States. With the advice of outside counsel, the Company believes there was insufficient evidence of equivalents presented and, consequently, for this and other reasons the verdicts were in error. The Company is working vigorously in the Appeals Court to overturn the verdicts and believes that it has strong arguments that its blankets do not infringe Augustine's patents. Based on all the facts available to management, the Company believes that it is reasonably possible but not probable that the jury verdict and the trial court injunction will be upheld on appeal. If damages were assessed in the same manner as determined by the jury for sales subsequent to September 30, 1997 plus interest on the estimated total, the total liability would approximate $25.1 million at September 30, 1998. The Company has not recorded an accrual for payment of the damages, because an unfavorable outcome in this litigation is, in management's opinion, reasonably possible but not probable. See Part II, Item 1 "Legal Proceedings" for additional information about this and related claims by Augustine against the Company. 5. The Company is subject to various investigations, claims and legal proceedings covering a wide range of matters that arise in the ordinary course of its business activities. In addition, the Company is in varying stages of active investigation or remediation of alleged or acknowledged contamination at 23 currently or previously owned or operated sites and at 15 off- site locations where its waste was taken for treatment or disposal. See Part II, Item 1 "Legal Proceedings" for additional information about legal proceedings involving the Company. Once the Company becomes aware of its potential environmental liability at a particular site, the measurement of the related environmental liabilities to be recorded is based on an evaluation of currently available facts such as the extent and types of hazardous substances at a site, the range of technologies that can be used for remediation, evolving standards of what constitutes acceptable remediation, presently enacted laws and regulations, engineers and environmental specialists' estimates of the range of expected clean-up costs that may be incurred, prior experience in remediation of contaminated sites, and the progress to date on remediation in process. While the current law potentially imposes joint and several liability upon each party at a Superfund site, the Company's contribution to clean up these sites is expected to be limited, given the number of other companies which have also been named as potentially responsible parties and the volumes of waste involved. A reasonable basis for apportionment of costs among responsible parties is determined and the likelihood of contribution by other parties is established. If it is considered probable that the Company will only have to pay its expected share of the total clean-up, the recorded liability reflects the Company's expected share. In determining the probability of contribution, the Company considers the solvency of the parties, whether responsibility is disputed, existence of an allocation agreement, status of current action, and experience to date regarding similar matters. Current information and developments are regularly assessed by the Company, and accruals are adjusted on a quarterly basis, as required, to provide for the expected impact of these environmental matters. The Company has established accruals only for those matters that are in its view probable and estimable. Based upon information currently available, management believes that existing accruals are sufficient to satisfy any known environmental liabilities, and that it is not reasonably possible at this time that any additional liabilities will result from the resolution of these matters that would have a material adverse effect on the Company's consolidated results of operations or financial position. 6. The following table sets forth the computation of basic and diluted earnings (loss) from continuing operations per common share (in millions, except shares and per share amounts). Three Months Ended September 30, ---------------------- 1998 1997 -------- --------- Numerator: Earnings (loss) from continuing operations $ 31.7 $(290.9) Preferred stock dividends (.1) (.1) -------- --------- Numerator for basic and diluted earnings (loss) per share--income (loss) available to common shareholders $ 31.6 $ (291.0) ======== ========= Denominator: Denominator for basic earnings (loss) per share--weighted-average shares 72,917,133 72,475,530 Potential dilutive common shares-- employee stock option 86,766 ---------- ---------- Denominator for diluted earnings (loss) per share--adjusted weighted-average shares 73,003,899 72,475,530 ========== ========== Basic earnings (loss) from continuing operations per common share $ .43 $ (4.02) ======= ========= Diluted earnings (loss) from continuing operations per common share $ .43 $ (4.02) ======= ========= The diluted share base for the three months ended September 30, 1997 excluded incremental shares of 681,423 related to employee stock options. These shares were excluded due to their antidilutive effect as a result of the Company's loss from continuing operations during this period. 7. The components of inventory included the following as of September 30, 1998: (In millions) Raw materials and supplies $ 206.6 Work in process 47.2 Finished goods 251.8 -------- $ 505.6 ======== 8. The Company has authorized and issued 100,000 shares, 98,330 outstanding at September 30, 1998, of par value $100, 4 percent cumulative preferred stock. The Company has authorized 1,400,000 shares, par value $1, of series preferred stock, none of which was outstanding during 1999 and 1998. Shares included in treasury stock were: September 30, June 30, 1998 1998 ------------- ---------- Common stock 15,597,215 13,941,638 4 Percent cumulative preferred stock 1,670 1,670 9. Common shares reserved at September 30, 1998 consisted of the following: Exercise of common stock purchase rights 82,360,270 Exercise of stock options and granting of stock awards 10,841,196 ---------- 93,201,466 ========== 10. Supplemental cash flow information for the three months ended September 30 included: (In millions) 1998 1997 -------- -------- Interest paid $ 27.7 $ 12.7 Income taxes paid 43.3 4.8 Noncash investing and financing activities: Assumption of liabilities related to an acquisition 488.5 Issuance of stock for investment plan match 6.0 9.7 Restricted stock award 10.0 11. Effective July 1, 1998, the Company adopted Financial Accounting Standards Board Statement No. 130, "Reporting Comprehensive Income" (SFAS 130). SFAS 130 establishes new rules for the reporting and display of comprehensive income and its components. Comprehensive income includes net income and other comprehensive income/(expense). Other comprehensive income/(expense) includes foreign currency translation adjustments and unrealized gains and losses on investments which prior to adoption were reported separately in shareholders' equity. Total comprehensive income for the three months ended September 30 was as follows: (In millions) 1998 1997 -------- -------- Net earnings (loss) $ 54.3 $(299.3) Other comprehensive income/(expense): Currency translation adjustment 21.2 (7.0) Net unrealized gain (loss) on investment securities (3.7) 3.4 Tax benefit related to items of other comprehensive income 1.4 -------- -------- Other comprehensive income (expense), net of tax 18.9 (3.6) -------- -------- Total comprehensive income (loss) $ 73.2 $(302.9) ======== ======== As of September 30, 1998, the cumulative balances for currency translation adjustment loss and the unrealized loss on investment securities were $49.9 million and $3.8 million, respectively. Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. (1) All references to years are to fiscal years ended June 30 unless otherwise stated. Certain amounts in the prior year have been reclassified to conform to the current year presentation. All earnings per share amounts are calculated on a diluted basis unless otherwise stated. Overview - -------- As disclosed in previous filings, in connection with the Company's filing of a shelf registration for debt securities, Mallinckrodt was engaged in discussions with the staff of the SEC regarding the purchase price allocation related to the acquisition of Nellcor. The Company has concluded these discussions with the SEC and, as a result, has agreed to recalculate and restate the amount of purchase price allocated to purchased research and development under a methodology preferred by the SEC as articulated publicly in an SEC letter to the AICPA in September 1998. The amount of purchased research and development charged to operations in the first quarter of 1998 of $398.3 million has been reduced by $90 million to $308.3 million. A corresponding $90 million increase in goodwill is being amortized on a straight-line basis over the previously established 30-year amortization period beginning in September 1997. The effects of this change on previously reported consolidated financial statements are shown in the Company's Annual Report on Form 10-K/A No. 1 for the year ended June 30, 1998. The effects of this change on previously reported condensed consolidated financial statements for the three months ended September 30, 1998 and 1997 are shown in Note 1 of Notes to Condensed Consolidated Financial Statements. Management's Discussion and Analysis of Financial Condition and Results of Operations reflects these adjustments in all periods of 1999 and 1998 presented and discussed below. Results of Operations General - ------- The Company recorded earnings from continuing operations of $31.7 million, or 43 cents per share for the quarter ended September 30, 1998. Earnings from continuing operations for the same quarter last year, before including $317.8 million of noncash charges related to the acquisition of Nellcor, were $26.9 million, or 37 cents per share. The acquisition of Nellcor was accounted for under the purchase method of accounting and, accordingly, the results of operations of Nellcor have been included in the Company's consolidated financial statements since September 1, 1997. The purchase price of the acquisition was allocated to the assets acquired and liabilities assumed based upon generally accepted accounting principles and estimated fair values at the date of acquisition. Actual revenues of some significant acquired in-process projects have experienced shortfalls when compared to revenue estimates developed as of the acquisition date. These shortfalls are primarily attributable to delays in receiving regulatory clearance to market and/or problems with production ramp up activities which often occur at the early stages of manufacturing a new product. The Company believes that such revenue shortfalls experienced to date do not indicate that these products will not meet customer needs or their long-term revenue expectations. These delays/problems can have an impact on sales for the first several quarters versus the plan established at the date of acquisition because of the typically steep increase in sales which occurs with the introduction of a new product; however, such delays are usually inconsequential over the life of the product. Thus, management believes the delays/problems experienced to date of some significant products will not reduce the expected long-term revenues of these products, but only the timing of the receipt of these revenues. - ----------------------------- (1) CAUTIONARY STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995: Our discussion and analysis in this quarterly report contain some forward-looking statements. Forward-looking statements do not relate strictly to historical or current facts, but rather give our current expectations or forecasts of future events. Forward-looking statements may be identified by their use of words such as "plans," "expects," "will," "anticipates," "believes," and other words of similar meaning. Such statements may address, among other things, the Company's strategy for growth, product development, regulatory approvals, the outcome of contingencies such as legal proceedings, market position, expenditures, and financial results. Forward-looking statements are based on current expectations of future events. Such statements involve risks and uncertainties and actual results could differ materially from those discussed. Among the factors that could cause actual results to differ materially from those projected in any such forward-looking statements are as follows: the effect of business and economic conditions; the impact of competitive products and continued pressure on prices realized by the Company for its products; constraints on supplies of raw materials used in manufacturing certain of the Company's products; capacity constraints limiting the production of certain products; difficulties or delays in the development, production, testing, and marketing of products; difficulties or delays in receiving required governmental or regulatory approvals; market acceptance issues, including the failure of products to generate anticipated sales levels; difficulties in rationalizing acquired businesses and in realizing related cost savings and other benefits; the effects of and changes in trade, monetary, and fiscal policies, laws, and regulations; foreign exchange rates and fluctuations in those rates; the costs and effects of legal and administrative proceedings, including environmental proceedings and patent disputes involving the Company; difficulties or delays in addressing "Year 2000" problems (as discussed in Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations); and the risk factors reported from time to time in the Company's SEC reports. The Company undertakes no obligation to update any forward-looking statements as a result of future events or developments. Net earnings for the first quarter of 1999 were $54.3 million, or 74 cents per share as compared to a net loss of $299.3 million, or $4.13 loss per share for the same period last year. Net earnings for the first quarter of 1999 included a gain of $22.6 million, or 31 cents per share on the sale of a chemical additives business, which related to a division reclassified to discontinued operations in 1998. The net loss for the same quarter of 1998 included a charge of $8.4 million, or 11 cents per share related to the cumulative effect of an accounting change discussed in Note 3 of the condensed consolidated financial statements. Net sales for the quarter were $591.2 million, up 30 percent from the $454.6 million in the same period last year. Sales to customers outside the United States were $181 million or 31 percent of total sales for the first quarter of 1999. A comparison of sales and operating earnings follows: (In millions) Three Months Ended September 30, --------------------- 1998 1997 -------- -------- Net sales Respiratory $ 256.2 $ 141.9 Imaging 182.9 177.3 Pharmaceuticals 152.1 135.4 -------- -------- $ 591.2 $ 454.6 ======== ======== Operating earnings (loss) Respiratory $ 22.4 $ 22.2 Imaging 30.7 23.1 Pharmaceuticals 20.5 12.4 -------- -------- 73.6 57.7 Corporate expense (7.0) (5.5) -------- -------- 66.6 52.2 Acquisition charges (324.9) -------- -------- $ 66.6 $(272.7) ======== ======== Operating earnings for the quarter ended September 30, 1998 were $66.6 million, which is a 28 percent improvement over the same period of fiscal 1998 before acquisition-related charges. In the first quarter of last year, the Company recorded an operating loss of $272.7 million, which included noncash charges of $306.3 million for the write-off of purchased research and development and $18.6 million related to the sale of Nellcor inventories which were stepped up to fair value in connection with the Nellcor acquisition. The Respiratory Group, of which Nellcor is now a part, had sales of $256.2 million or 81 percent greater than the sales recorded for the same period last year. The prior year results included only one month of Nellcor sales and operating results. The Group's sales increase of $114.3 million was attributable to volume growth of 85 percent, of which 72 percent was due to the inclusion of only one month of Nellcor revenue in 1998, partially offset by price declines primarily involving anesthesia and respiratory devices. Operating earnings for the Group for the quarter were $22.4 million or 1 percent above the prior year. In spite of the benefits of the increased sales, the earnings comparison with prior year was negatively impacted by two months of additional expenses, which included additional amortization of intangibles and goodwill of $8.4 million. The Imaging Group had sales of $182.9 million or 3 percent above the prior year period of $177.3 million. The sales improvement was attributable to a $7.8 million increase in nuclear medicine product volume which offset the $2.2 million decline in the other product lines comprising the Group. Operating earnings for the Group were $30.7 million or 33 percent above the $23.1 million recorded for the same period last year. The operating earnings improvement was attributable to volume growth, lower rebates, expense control and increased manufacturing efficiencies. Although price declines in the x-ray contrast media portion of the business were not a major factor in the year to year comparison of results for the first quarter, it is probable that this will be a factor impacting subsequent quarters of this fiscal year. The demand for price discounts is expected to increase and reduce profitability in 1999, but at a lower rate of decline than was experienced in 1998 and 1997. The Pharmaceuticals Group sales for the quarter ended September 30, 1998 were $152.1 million or 12 percent greater than in the same period last year. The sales increase of $16.7 million was primarily attributable to volume increases in narcotics and drug chemicals of $15 million and $4 million, respectively, offset by volume declines in acetaminophen and lab and microelectronics. Price increases generated 3 percent of the year over year sales increase. Operating earnings for the Group were $20.5 million or 65 percent greater than the $12.4 million recorded in the comparable period last year. The operating earnings improvement was primarily attributable to increased sales of higher margin bulk and dosage narcotics and to improved operating rates at manufacturing facilities. Corporate Matters Corporate expenses were $7.0 million, or 27 percent above the level reported for the same period last year. Interest and other nonoperating income, net was $.9 million for the quarter as compared with $9.2 million for the same period last year. In 1998, the Company generated interest income on cash proceeds from 1997 divestitures invested in interest bearing securities. These cash equivalents were utilized to acquire Nellcor at the end of August 1997. The Company's effective tax rate was 32.4 percent for the quarter ended September 30, 1998. The tax rate for the same period last year, after excluding the one-time noncash write-off of purchased research and development of $306.3 million which had no tax benefit, was 37.1 percent. The improvement in 1999 was primarily attributable to changes in earnings mix between higher tax rate and lower tax rate entities associated with the acquisition of Nellcor. Financial Condition The Company's financial resources are expected to continue to be adequate to support existing businesses. Since June 30, 1998, cash and cash equivalents increased $2.6 million. Operations utilized $31.3 million of cash, while capital spending totaled $27.3 million. The Company received $55.1 million in proceeds from asset disposals. The Company's current ratio at September 30, 1998 was 1.0:1. Debt as a percentage of invested capital was 56.1 percent. In December 1997, the Company filed a $500 million shelf debt registration statement which has not, as yet, been declared effective. At September 30, 1998, the Company has a $1.0 billion private placement commercial paper program. The program is backed by a $1.0 billion revolving credit facility expiring September 12, 2002. The revolving credit facility was reduced from $1.6 billion to $1.0 billion in September 1998. There was no borrowing outstanding under the revolving credit facility at September 30, 1998. Commercial paper borrowings under this program were $345.0 million as of September 30, 1998. Non-U.S. lines of credit totaling $127.8 million were also available, and borrowings under these lines amounted to $19.2 million at September 30, 1998. The non-U.S. lines are cancelable at any time. The Company's Board of Directors previously authorized repurchase of 47 million shares of common stock and additional repurchases not to exceed cash outlays of $250 million. Share repurchases under these authorizations have totaled 38.7 million shares, including 1.9 million shares during the three months ended September 30, 1998. Estimated capital spending for the year ending June 30, 1999 is approximately $140 million. Year 2000 Update - ---------------- The Year 2000 issue is the result of date-sensitive devices, systems and computer programs that were deployed using two digits rather than four to define the applicable year. Any such technologies may recognize a year containing "00" as the year 1900 rather than the year 2000. This could result in a system failure or miscalculations causing disruptions of operations including, among other things, a temporary inability to process transactions or engage in similar normal business activities. The Company has completed its assessment of its information systems which support business applications and is in the late stages of modifying or replacing those portions of the software that are required. The assessment of products sold to customers has also been completed and necessary remediation is being accomplished. Assessment and remediation of research and development, manufacturing processes and facility management systems are underway. The Company is also assessing the readiness of its key suppliers and business partners to be Year 2000 compliant. Information requests have been distributed and replies are being evaluated. If the risk is deemed material, the Company is prepared to perform on-site visits to those businesses to verify the adequacy of the information received. All of these modification, replacement or conversion efforts should be substantially complete during the first quarter of calendar 1999, which is prior to any anticipated significant impact on Mallinckrodt's operations. Based upon the accomplishments to date, no modification or conversion contingency plans are expected to be needed and therefore none have been developed. Because of substantial progress to date and plans that contemplate being substantially complete in the first quarter of calendar 1999, we believe adequate time will be available to insure modification alternatives could be developed, assessed and implemented prior to a Year 2000 issue having a material negative impact on the operations of the Company. To further recognize potential adverse impact, the Company is developing operating contingency plans to address unanticipated interruptions that could occur in processes, systems and devices that have been assessed, remediated and considered Year 2000 ready by Mallinckrodt and its key suppliers and business partners. Such operating contingency plans are expected to be substantially complete before June 30, 1999. Both internal and external resources are being used to reprogram or replace non-compliant technologies, and to appropriately test Year 2000 modifications. Such modifications are being funded through operating cash flows. The project to address Year 2000 has been underway since February 1997. The pretax costs incurred for this effort were approximately $7 million and $1 million in 1998 and 1997, respectively. The Company anticipates expenses of approximately $13 million will be incurred in 1999 to substantially complete the effort. The cost of the project and the date on which the Company believes it will substantially complete Year 2000 modifications are based on management's best estimates. Such estimates were derived using software surveys and programs to evaluate calendar date exposures and numerous assumptions of future events, including the continued availability of certain resources and other factors. Because none of these estimates can be guaranteed, actual results could differ materially from those anticipated. Specific factors that might cause such differences include, but are not limited to, the availability and cost of personnel trained in this area, the ability to locate and correct all relevant computer codes, and similar uncertainties. If the modifications and conversions are not made or are not completed timely and operating contingency plans developed do not work as anticipated, the result could be an interruption, or a failure, of certain normal business activities or operations. Such failures could materially impact and adversely affect the Company's results of operations, liquidity and financial condition. Readers are cautioned that forward looking statements contained in this Year 2000 Update should be read in conjunction with the Company's disclosures under the heading "CAUTIONARY STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995" on page 7. European Monetary Union (EMU) - ----------------------------- The euro is scheduled to be introduced on January 1, 1999, at which time the eleven participating EMU member countries will establish fixed conversion rates between their existing currencies (legacy currencies) and the euro. The legacy currencies will continue to be valid as legal tender through June 30, 2002; thereafter, the legacy currencies will be canceled and euro bills and coins will be used for cash transactions in the participating countries. The Company's European sales offices and various manufacturing and distribution facilities affected by the euro conversion have established plans to address the systems issues raised by the euro currency conversion and are cognizant of the potential business implications of converting to a common currency. The Company is unable to determine the ultimate financial impact of the conversion on its operations, if any, given that the impact will be dependent upon the competitive situations which exist in the various regional markets in which the Company participates and the potential actions which may or may not be taken by the Company's competitors and suppliers. PART II. OTHER INFORMATION Item 6. Exhibits and Reports on Form 8-K. (a) Exhibits Exhibit Number Description - ------- -------------------------------------------------------- 10.29 Executive Incentive Compensation Plan for Fiscal 1999 (incorporated herein by reference to Exhibit 10.29 to September 30, 1998 Form 10-Q) 27 Financial data schedule for the quarter ended September 30, 1998 (filed with this electronic submission) - --------------------- (1) Management contract or compensatory plan required to be filed pursuant to Item 601 of Regulation S-K. (b) Reports on Form 8-K. During the quarter and through the date of this report, the following report on Form 8-K was filed. - - Report dated July 6, 1998 under Item 5 regarding the closure of Nellcor Puritan Bennett Incorporated facilities in Lenexa, Kansas. * * * * * * * * * * * * * * SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Mallinckrodt Inc. - ---------------------------- Registrant By: /s/ MICHAEL A. ROCCA By: /s/ DOUGLAS A. MCKINNEY --------------------------- ----------------------------- Michael A. Rocca Douglas A. McKinney Senior Vice President and Vice President and Controller Chief Financial Officer Date: February 16, 1999
EX-27 2
5 This schedule contains summary financial information extracted from the consolidated balance sheets and consolidated statements of operations of the Company's Form 10-Q/A No. 1, and is qualified in its entirety by reference to such financial statements. 1,000,000 3-MOS JUN-30-1999 SEP-30-1998 58 0 470 18 506 1194 1450 547 3873 1142 944 0 11 87 933 3873 591 591 318 525 0 0 21 47 15 32 22 0 0 54 .74 .74
-----END PRIVACY-ENHANCED MESSAGE-----